Skip to main navigation

4D Molecular Therapeutics

    About

  • About
    • Company Overview
    • Purpose & Strategy
    • FOUNDERS
    • Leadership Team
    • Board of Directors
    • CONTACT US
  • Technology

  • Technology
    • GENE THERAPY
    • Conventional Vectors
    • 4DMT Therapeutic Vector Evolution
    • Scientific Presentations
  • Product Pipeline

  • Product Pipeline
    • Pipeline Overview
    • Ophthalmology
    • Cardiology
    • Pulmonology
  • Patients & Advocacy

  • Patients
    • Overview
    • Clinical Trials
      • XLRP 4D-125
      • XLRP Natural History
      • CHM 4D-110
      • FABRY 4D-310
    • Advocacy Partners
    • Community Outreach
    • Patient Stories
    • Resources
  • IR Nav

  • Investors
    • Overview
    • Events & Presentations
    • Press Releases
    • SEC Filings
    • Stock Information
    • Analyst Coverage
    • Corporate Governance
  • Careers

  • Careers and Culture
    • Overview and Openings
    • Competitive Compensation
    • Benefits, Balance and Well-being
    • Growth and Development
    • Culture and Community
Menu

Investors & Media

Corporate Governance

Corporate Governance

Committee Charters
Audit Committee Charter 87.3 KB
Compensation Committee Charter 92 KB
Nominating and Corporate Governance Committee Charter 76.9 KB
Governance Documents
Corporate Governance Guidelines 99.8 KB
Code of Business Conduct and Ethics 105.4 KB
Whistleblower Policy 187.5 KB

Committee Composition

Audit Compensation Nominating & Governance
Jacob Chacko, MD, MBA Audit Nominating & Governance
Susannah Gray, MBA Audit Compensation
Nancy Miller-Rich Compensation
Charles P. Theuer, MD, PhD Audit Nominating & Governance
Shawn Tomasello Compensation Nominating & Governance
= Chairperson = Member

Contacts

Media

Ingrid Mezo
CanaleComm
Ingrid.mezo@canalecomm.com
301-473-2881

Investors

Mike Zanoni
mzanoni@4dmt.com
610-442-8570

Request Email Alerts

 
Share

Social icons

Linkedin Facebook

    About

  • About
  • Technology

  • Technology
  • Product Pipeline

  • Product Pipeline
  • Patients & Advocacy

  • Patients
  • IR Nav

  • Investors
  • Careers

  • Careers and Culture
  • Home

  • Home
  • Terms of Use

  • Terms of Use
© 2022 4D Molecular Therapeutics, All Rights Reserved